ArticleWorld journal of diabetes2011
Assessing and treating insulin resistance in women with polycystic ovarian syndrome.
Article in World journal of diabetes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 77 citations in OpenAlex.
- Pooled it
- A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary Syndrome.Frontiers in endocrinology · 2022Pooled it
- Pooled it
- Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial.Journal of ovarian research · 2024Trial
- Clustering of overweight and obese young adults based on their nutritional patterns and psychological state.Health psychology and behavioral medicine · 2025Article
- Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome.BMC women's health · 2024Article
- Relationship between polycystic ovary syndrome and high periostin level.Revista da Associacao Medica Brasileira (1992) · 2024Article
- Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.Clinical medicine insights. Endocrinology and diabetes · 2024Article
- Is There Still a Place for Surgery in Patients with PCOS? A Review.Life (Basel, Switzerland) · 2023Review
- Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment.Journal of ovarian research · 2023Review
- Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.Lipids in health and disease · 2020Article
- The correlation between insulin-like growth factor binding protein 1 (IGFBP-1) and homeostasis model assessment of insulin resistance (HOMA-IR) in polycystic ovarian syndrome with insulin resistance.International journal of reproductive biomedicine · 2018Article
- Association of single-nucleotide polymorphisms rs2197076 and rs2241883 of FABP1 gene with polycystic ovary syndrome.Journal of assisted reproduction and genetics · 2016Article
- Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.PloS one · 2015Article
- Association of common variants of FTO in women with polycystic ovary syndrome.International journal of clinical and experimental pathology · 2015Article
- Mixed form of hirsutism in an adolescent female and laser therapy.Iranian Red Crescent medical journal · 2014Article
- Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.Indian journal of clinical biochemistry : IJCB · 2013Article
- Defining the role of bariatric surgery in polycystic ovarian syndrome patients.World journal of diabetes · 2012Article
- Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats.Reproductive biology and endocrinology : RB&E · 2012Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovarian syndrome (PCOS) is a highly prevalent hormonal and metabolic disorder among reproductive aged women worldwide. Women with PCOS have widely varying phenotypes and seek medical care for differing reasons. In addition to concern for menstrual cycle function, ovulation, hirsutism and acne, many PCOS women have abnormal glucose metabolism. While diabetes mellitus and impaired glucose tolerance are easily diagnosed, the diagnosis of and concern for insulin resistance as a precursor disorder is underappreciated. Insulin resistance may be the first important marker of metabolic disease in PCOS women at risk for metabolic syndrome and coronary artery disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.